Indy Hematology Review
Avatar

Therapy for Newly Diagnosed Myeloma - Role of Transplant and MRD, DARA-VRd vs.VRd Trial, Lenalidomide Maintenance Therapy, Achieving MRD- with ASCT and Adding Isatuximab to VRd

By Indy Hematology Review FEATURING Kenneth Anderson
By Indy Hematology Review FEATURING Kenneth Anderson
0 views
June 7, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Recommended

AUTOPLAY
19:08
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGU…

Feat. R. Banerjee
32:06
Scripps Health

Should Patients With High-Risk SMM Be Treated Outside a Clinical Tri…

Feat. M. Gertz
35:27
Dana-Farber Cancer Institute

Advances in Multiple Myeloma 2024: From Bench to Bedside

Feat. K. Anderson
15:36
Memorial Sloan Kettering Cancer Center

Key Myeloma & MGUS Updates From ASH

Feat. S. Mailankody
28:20
PleXus Communications

Why We Should Not Treat SMM

Feat. B. Derman
04:15
Indy Hematology Review

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Feat. M. Gertz
12:33
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Minimizing Uncertainty in Multiple Myelom…

Feat. K. Patel
11:55
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "CENTAURUS Study Final Analysis - Efficacy &…

Feat. O. Landgren
23:09
5th SOHO Italy Annual Conference

SOHO Italy 2023: Is Anti-CD38-Based Induction Therapy for Every Pati…

Feat. P. Richardson
28:11
Total Health

Hematologic Malignancies Update: Treatment Strategies for AML, DLBCL…

Feat. M. Rotta
32:03
Indy Hematology Review

Emerging and Current Treatment of MM: What Should We Know and What S…

Feat. K. Anderson
09:39
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Impact of Dex Dose Strength on Outcomes in …

Feat. R. Banerjee
41:54
University of Colorado Division of Hematology

Overview of Pathophysiology, Diagnosis and Management of Multiple My…

Feat. K. Sidor
52:39
Yale Cancer Center

Myeloma in 2023: So Many Drugs, Yet So Few Cures

Feat. A. Chari
22:15
5th SOHO Italy Annual Conference

SOHO Italy 2023: Multiple Myeloma Cured in 2030 - What Are the Next …

Feat. K. Anderson
06:11
Insights from 2023 EHA® Annual Meeting

EHA® 2023 Insights: "An Outpatient Model for Teclistamab Step-U…

Feat. A. Varshavsky-Yanovsky
10:23
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "iStopMM Study - Revised Definition of Free …

Feat. T. Einarsson Long
30:18
UChicago Medicine

Practice-Changing and Promising New Treatments in Myeloma

Feat. B. Derman
41:52
MyCancerHaven

How I Approach Frontline Treatment for Patients With MM

Feat. R. Vij, S. Goyal
04:55
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "iStopMM Study - Risk Factors of Smoldering …

Feat. S. Thorsteinsdottir